Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study

所属期刊栏目：13

资助基金：Merck Sharp & Dohme;who sponsored the study.The support for the manuscript development was provided by Merck & Co.,Inc.Whitehouse Station,NJ,USA.The authors are grateful for the contribution made by Bo-Jing Cai Merck & Co.,Inc. in the data management and statistical analysis

在线出版日期：2019-07-04（万方平台首次上网日期，不代表论文的发表时间）

页数：共13页

页码：365-377